Atex Expands TEMIS Partnership and Announces 7 new deals

30 November 2010 - Reading, UK - Atex and TEMIS announce that seven customers have already selected the Atex Polopoly Web CMS and the TEMIS Content Enrichment solution.

Joint customers are leveraging the integrated solution to automate their publishing processes through the Polopoly Web CMS platform, including creating rich content packages, generating semantic driven landing pages, interlinking content and powering XML-based advanced search functionality.

“The Atex Web CMS and TEMIS  Content Enrichment solution is proving itself with leading media companies around the world as a single-vendor system that drives traffic, increases page views and time spent on sites, attracts unique visitors, thereby  driving revenues for the publisher,” said Jean Paul Chauvet, Executive Vice President, Global Sales and Marketing, Atex. “Atex is soon to launch the new Polopoly 10 to include further integration with the TEMIS Content Enrichment solution, so the benefits to adopters of the system will further increase.”

“We are thrilled with the expansion of our partnership with Atex. This alliance represents a significant growth opportunity for TEMIS and aligns with our strategy to expand our global footprint,” said Charles Huot, COO, TEMIS. “Luxid® helps publishers around the world to add value to their content by extracting a wide range of entities and insights from text, creating richer metadata that allows for semantic navigation.”

Combined with a leading Web CMS system like Polopoly 10, Luxid® increases the “discoverability” of content, enables Publishers to repurpose their content assets and create new custom products, greatly improves Search Engine Optimisation to attract new visitors, raises the number of page views through smarter links, and finally creates new advertising opportunities by linking ads to relevant content.

Going forward additional capabilities such as sentiment analysis will also be available across all content. This will allow for social media to be further enriched with the addition of automatic tagging and classification, hence improving user generated content, blogs, forums, rating and voting for example.

The rich functionalities of the product suite will be showcased at the Online Information Conference, London Olympia- 30th November to 2nd December where both Atex (stand #338) and TEMIS (stand #532) will be hosting on demand demonstrations.
Anyone wishing to arrange a meeting or demonstration in advance should contact jtaylor@atex.com or info@temis.com.

Jonathan Twomey, Atex Technical Sales EMEA will be presenting on Tuesday, November 30th at 11.45 in the STM seminar session, “ Let’s get Physical, an up close study of the AIP Platform” and on Thursday, December 2nd at 15.00 in the Content Management stream – “Going Digital”.

Peter Camilleri, Director, TEMIS Europe, will be presenting "From Content Enrichment to Smarter Content" on Wednesday, December 1st at 14:45 in the Enterprise Search Theatre C.
 

About TEMIS
TEMIS is the leading provider of Text Analytics software solutions for the Enterprise. Its cutting-edge solution Luxid® addresses the needs of life sciences, enterprise, publishing and homeland security. Its powerful information intelligence capabilities power strategic corporate activities such as competitive intelligence, scientific discovery, opinion mining, voice of the customer and content publishing. Luxid® turns unstructured data into actionable knowledge, enabling advanced content analysis and strategic information discovery.

Founded in 2000, TEMIS operates in the United States, Canada, UK, France and Germany, and is represented worldwide through its network of certified partners. TEMIS' innovative solutions have attracted the business of leading organizations such as Agence France-Presse, BASF, Bayer Schering Pharma, BNP Paribas, Boehringer Ingelheim, CARMA International, Editions Lefebvre-Sarrut, Elsevier, EMC, Europol, French Ministry of Defence, French Ministry of Finance, Invest in France Agency, Merck Serono, Nature Publishing Group, Novartis, Philip Morris International, PSA Peugeot-Citroen, Roche Diagnostics, Sanofi-aventis, Solvay Pharmaceuticals, Springer Science+Business Media, The McGraw-Hill Companies, and Thomson Reuters.
www.temis.com